Pathology and Prognosis of Persistent Stable Pure Ground-Glass Opacity Nodules After Surgical Resection
|
|
- Douglas Griffin
- 5 years ago
- Views:
Transcription
1 GENERAL THORACIC Pathology and Prognosis of Persistent Stable Pure Ground-Glass Opacity Nodules After Surgical Resection Sukki Cho, MD, HeeChul Yang, MD, Kwhanmien Kim, MD, and Sanghoon Jheon, MD Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Gyeonggi; and Department of Thoracic and Cardiovascular Surgery, College of Medicine, Seoul National University, Seoul, Korea Background. This study aimed to show the pathologic results of pure ground glass opacities (pggos) that showed no change in patients who underwent surgical resection. Methods. The data used in this study were collected from the records of patients who underwent surgical resection for pggos between January 2004 and December All pggos were detected and followed up until operation with high-resolution computed tomography at our hospital and were followed up by computed tomography of the chest at least 2 years after operation. Surgical resection was performed for patients with pggos if no change was observed after a minimum of 1 month of follow-up and if any growth of the nodules or newly formed solid components occurred in pggos of any size. Results. Forty-six patients were enrolled into the study group. No changes in the pggos during serial follow-up occurred in 39 patients (84.8%), and 7 patients (15.2%) underwent surgical resection because of growth of the lesions or newly developed solid lesions during follow-up. Of 39 patients in the no-change group, pathologic types of the cancerous pggos in 23 patients included adenocarcinoma in situ in 21 patients, minimally invasive adenocarcinoma in 1 patient, and invasive adenocarcinoma in 1 patient. In the change group, 5 patients were diagnosed with cancer. Between the two groups, there was no difference in sex, time intervals, or tumor size. Neither group had lymph node metastasis or recurrence. Conclusions. This study showed the pathology of persistent stable pggo postoperatively, which confirmed the 59% chance of a cancer diagnosis including adenocarcinoma in situ, minimally invasive adenocarcinoma, or invasive adenocarcinoma. (Ann Thorac Surg 2013;96:1190 5) Ó 2013 by The Society of Thoracic Surgeons The number of cases of early detection of focal ground-glass opacity nodules (GGOs) has been increasing exponentially because of computed tomography (CT) screening programs and with advances in the quality of high-resolution computed tomography (HRCT). GGOs can be classified further as either pure GGOs (pggos) or mixed GGOs. Nodules of the former type are round, homogeneous, well-defined lesions harboring no areas of soft tissue density, whereas in the latter type, the area of parenchymal architecture is completely obscured within the nodule [1]. Among them, persistent GGOs are thought to have a strong malignant potential, and they also correspond to focal fibrosis, atypical adenomatous hyperplasia (AAH), and early-stage lung cancer [2, 3]. Most lung cancer featuring pggos is diagnosed as adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), or, rarely, as invasive adenocarcinoma. Therefore, lung cancer featuring pggos, compared with solid types of lung cancer, rarely shows lymph node metastasis and has an outstanding prognosis, wherein the 5-year recurrence-free survival approaches 100% [4]. Accepted for publication May 17, Address correspondence to Dr Cho, Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, 166, Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, , Republic of Korea; skcho@snubh.org. As thoracic surgeons have gained more experience with pggos a question has arisen regarding whether pggos require immediate surgical intervention, which has led long-term follow-up as a favorable option in their treatment. Although the surgical indications for GGO lesions are not well established, generally, when the size of a pggo lesion grows or when a newly developed solid component is observed, the operation may be performed. However, in most cases, pggo lesions neither change in size nor develop a solid component for a long time, and little is known about the pathologic findings in persistent pggos without those changes or about the prognosis of those that are diagnosed as cancer. Existing studies dealing with the natural history of pggos have been limited in determining the nature of unchanging but persistent pggos because those studies have reported only follow-up results without histologic analysis [5]. Therefore, this study aimed to show the pathologic results of pggos with no changes in patients who underwent surgical resection. Patients and Methods Patients The data used in this study were collected from the records of patients who underwent surgical resection Ó 2013 by The Society of Thoracic Surgeons /$36.00 Published by Elsevier Inc
2 Ann Thorac Surg CHO ET AL 2013;96: GROUND-GLASS OPACITY NODULES AFTER SURGICAL RESECTION for pggos between January 2004 and December We excluded patients with tumors that were 100% solid or mixed GGOs, or with tumor sizes larger than 3 cm. In the enrolled patients, all pggos were detected and followed up until operation with HRCT at our hospital. After the operation, all patients who were diagnosed with any type of lung cancer were observed at 3-month intervals with computed tomography (CT) of the chest, and patients who did not have a chest CT after a followup period of at least 2 years were also excluded from this study. This study was approved by the institutional review board of Seoul National University Bundang Hospital, and patients informed consent was waived because of the retrospective nature of the study design. Calculation of GGO Component The proportion of GGOs in a nodule was measured in the same way as that reported elsewhere [6]. In brief, the images were photographed with a window level of 600 H and a window width of 2,000 H as the lung window. The GGO was defined as a hazy increase in lung attenuation that did not obscure the underlying bronchial or vascular structures. Solid attenuation was defined as an increase in lung attenuation obscuring the underlying structures. A quantitatively estimated GGO area was defined as 1, the ratio of solid attenuation to the maximum tumor dimension. GGO lesions were classified as pure GGO lesions only if they had a 100% GGO proportion, and the remaining GGO lesions were classified as mixed GGO lesions [6, 7]. Surgical Indications In our institution, surgical resection was applied in three cases during this study period: (1) patients with pggos 10 mm or larger in diameter if no change was observed after the minimum 1-month follow-up period; (2) growth of the nodules or of newly formed solid components in pggos was detected during the follow-up HRCT; and 3) extrathoracic malignancy was present or, in the surgeons judgment based on their experience with pggos during this study period, initial CT findings strongly suggested cancer, in which case surgical resection was performed without a period of observation. Pathology The seventh edition of the tumor, node, metastasis (TNM) staging system for lung cancer was adopted for proper postoperative staging. Cell types were sorted by the regulations set forth in the 2011 guidelines of the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society [8]. An AIS is considered a cytologically bland lesion devoid of any invasion but able to progress to eventual invasive adenocarcinoma with the addition of further mutation and oncogene gene copy numbers. MIA is referred to as a lepidic predominant and low-grade tumor measuring 3 cm or less in diameter with an area of invasion limited to a maximum of 5 mm [8] Surgical Procedures During the study periods, there was a guideline for the extent of surgical resection. If the preoperative diagnosis was not confirmed, wedge resection by use of videoassisted thoracic surgery (VATS) (aided by CT-guided hook-wire localization in some cases) was done first, and the tissue was sent to the pathology laboratory for a frozen section. If the tissue was malignant, anatomic resection and mediastinal node dissection were usually performed, whereas limited resection including wide wedge resection or segmentectomy was pursued in selected cases. Prognosis Local/regional recurrence was defined as ipsilateral pulmonary metastasis, bronchial or parenchymal resection margin, or mediastinal node metastasis, and distant recurrence was defined as metastasis of the contralateral lung or distant organs. It was not considered a recurrence if changes in size or density were observed in the GGO lesions that had already existed at the initial chest CT or if the newly developed GGO lesions showed different pathologic-molecular features after resection. Statistical Analysis Student s t test was used to compare the distribution of continuous data, and Fisher s exact tests were used to compare the frequencies of categoric measures between the groups. Disease-free survival was defined as the time from operation to the first diagnosis of local or distant disease recurrence or until the last follow-up visit. Overall survival was defined as the time from operation to death or the last follow-up visit. Disease-free and overall survival curves were estimated with the Kaplan-Meier method, and significance was assessed with the log-rank test. Results Patients During the study period, 149 patients were operated on for focal GGO lesions (Table 1). Eighty-six patients with mixed GGO lesions, 7 patients with tumors larger than 3 cm, and 3 patients who had a follow-up period of less than 2 years for CT were excluded. Seven patients who underwent surgical resection immediately after diagnosis with pggos were also excluded from this study. As a result, 46 patients were enrolled in this study group: 39 patients (84.8%) experienced no change of their pggo nodules during serial follow-up, which met the major indication for operation, and 7 patients (15.2%) underwent surgical resection because of growth of the lesions or new development of solid lesions during follow-up. There were 29 male patients (63.0%), and the mean age was 57.9 years (range, 31 to 80 years). In 27 patients (58.7%), GGO lesions were incidentally found on the CT scan during their regular health check-ups. No-Change Group in All pggos Among the 39 patients of the no-change group, 24 were male (61.5%), and the mean age was 55.9 years GENERAL THORACIC
3 GENERAL THORACIC 1192 CHO ET AL Ann Thorac Surg GROUND-GLASS OPACITY NODULES AFTER SURGICAL RESECTION 2013;96: Table 1. Characteristics of pggos (n ¼ 46) Characteristic Frequency Sex, n (%) Male 29 (63.0) Female 17 (36.5) Age, mean (range), years 57.9 (31-80) Location, n (%) RUL/LUL 16 (34.8) / 11 (23.9) RML 1 (2.2) RLL/LLL 11 (23.9) / 7 (15.2) CT screening, n (%) No 19 (41.3) Yes 27 (58.7) Time intervals, n (%), days <90 5 (10.9) (34.8) (23.9) > (30.4) Surgical indications, n (%) No change 39 (84.8) Size or solid (þ) 7 (15.2) Surgical extent, n (%) Wedge 16 (34.8) Segmentectomy 7 (15.2) Lobectomy 23 (50.0) Pathology, n (%) Benign 18 (39.1) Cancer 28 (60.9) CT ¼ computed tomography; LLL ¼ left lower lobe; LUL ¼ left upper lobe; pggos ¼ pure ground glass opacities; RLL ¼ right lower lobe; RML ¼ right middle lobe; RUL ¼ right upper lobe. (range, 31 to 80 years) (Table 2). In terms of smoking history, 22 (56.4%) were never smokers, 11 (28.2%) were current smokers, and 6 (15.4%) were former smokers. The average time period from detection to operation was days, and the time periods from detection to operation were shorter than 3 months in 4 patients (10.3%), 3 to 6 months in 16 patients (41.0%), 6 to 12 months in 11 patients (28.2%), and longer than 12 months in 8 patients (20.5%). The median size of the tumors was 9.0 mm (range, 6 to 18 mm), and the tumor sizes were smaller than 10 mm in 25 patients (64.1%) and 10 to 20 mm in 14 patients (35.9%). Twenty-three patients (59.0%) were diagnosed with cancer after undergoing surgical resection, and 16 patients (41.0%) were diagnosed with benign tumors. There was no difference in sex, size, time period, and smoking history between the two groups. However, the mean age at operation in the benign group was lower than that in the cancerous group (49.8 vs 60.3 years, p ¼ 0.015). The types of operations performed in this group included lobectomy, segmentectomy, and wedge resection, and they were performed on 20 patients (51.3%), 5 patients (12.8%), and 14 patients (35.9%), respectively. Lobectomy, segmentectomy, and wedge resection were performed on 14 (60.9%), 4 (17.4%), and 6 patients (21.7%) with cancerous lesions, and 6 (37.5%), 1 (6.3%), and 9 patients (56.2%) with benign lesions, respectively. Pathologic types of cancerous pggos in 23 patients included AIS in 21 patients (91.4%), MIA in 1 patient (4.3%), and invasive adenocarcinoma in only 1 patient (4.3%). The tumor size in the patient with MIA was 16 mm on the preoperative CT scan. Even though there was no change in size for 116 days, surgical resection was performed at the patient s request, and the size of the invasive component was reported to be 5 mm. The tumor size in the patient with invasive adenocarcinoma was 15 mm, and surgical resection was performed after a 552-day follow-up period. This patient had a history of surgical resection for lung cancer 2 years before the observation period. By contrast, the benign disease group consisted of 13 patients with AAH and 3 patients with other conditions (each with fibrosis, hemorrhage, and metaplasia). Among the 39 patients with persistent pggos, multiple lesions were found only in those who were later diagnosed with cancer (n ¼ 7). All the multiple lesions were detected concurrently with the resected lesion. However, because they were located in different regions from the resected lesion, and all were smaller than 10 mm, it was decided to observe those lesions. Comparison Between No-Change Group and Change Group in Cancerous pggos Among the 7 patients of the change group, 5 patients (71.4%) were diagnosed with cancer (Table 3). Among those 5 cancerous patients, 3 were diagnosed with invasive adenocarcinoma and 2 with MIA. In comparison with the no-change group, there was no difference in sex, time intervals, or tumor size, but in the change group, the patients were a little older. Neither group had lymph node metastasis or recurrence. In terms of cell types, the number of cases of invasive adenocarcinoma in the change group was statistically significantly higher than that in the no-change group, although the number of the cases was small (p ¼ 0.022). Comment Most studies of pggos have been limited to discovering its natural history based on the information gained from long-term follow-up in the absence of surgical procedures. Because patients in those studies did not undergo operation, tissue confirmation was not made, which means that pggos that did not show any change in size could not be pathologically identified, and annual HRCT could not give any information other than the size of the nodules which did not show any change. Kodama and colleagues [9] conducted a study of 19 patients with pggo nodules, performed surgical resection on 10 patients of 11 with changes in size of the nodules, and diagnosed 5 of them with lung cancer. Because 4 of those 5 patients with lung cancer had undergone surgical procedures for lung cancer, they concluded that a history of lung cancer should significantly raise the index of suspicion. Chang and colleagues [5] also reported that more than 90% of patients with pggos did not experience any
4 Ann Thorac Surg CHO ET AL 2013;96: GROUND-GLASS OPACITY NODULES AFTER SURGICAL RESECTION Table 2. Difference Between Cancer and Benign Lesions in No-Change pggos (n ¼ 39) Characteristic Cancer (n ¼ 23) Benign (n ¼ 16) p Value Sex, male, n (%) 16 (69.6) 8 (50.0) Age, mean, years Smoking history, n (%) Never 12 (52.2) 10 (62.4) Current 8 (34.8) 3 (18.8) Former 3 (13.0) 3 (18.8) Time intervals, n (%), days <90 2 (8.7) 2 (12.5) (34.8) 8 (50.0) (21.7) 6 (37.5) >360 8 (34.8) 0 (0.0) Surgical extent, n (%) Wedge 5 (21.7) 9 (56.3) Segmentectomy 4 (17.4) 1 ( 6.3) Lobectomy 14 (60.9) 6 (37.4) Size on CT, median, mm Size on pathology, median, mm GENERAL THORACIC CT ¼ computed tomography; pggos ¼ pure ground glass opacities. tumor growth during the long-term follow-up period, and even in growing pggos, an indolent clinical course was noted. However, in that study as well, simple follow-up without pathologic confirmation was the only available option for most of the patients who showed no change in size, and as those authors explained, none of the patients in that study underwent tissue confirmation, meaning that they could not calculate the prevalence of primary lung cancer in this patient cohort. Surgical indications for pggos are described differently in various studies. Chang and colleagues [5] stated that if pggos displayed an internal solid portion or were greater than 10 mm in diameter, operation was considered if patient consent was provided. However, if the pggo was less than 10 mm in diameter and did not possess a solid portion, thinsection CT scans were obtained within a short follow-up period of 3 months, again at 6 months, and annually thereafter. To date, common surgical indications for pggos have included increasing size of the tumor or new development of the solid component. In our institution, our policy was that surgical resection could be performed if the lesion was larger than 1 cm, but if the lesion was smaller than 1 cm, the patient was put under observation first, and if the lesion grew in size or formed a solid component, then surgical resection was performed. However, as surgeons built up more experience with Table 3. Difference Between Change and No-Change Groups in Cancerous pggos Characteristic Change Group (n ¼ 5) No-Change Group (n ¼ 23) p Value Sex, male, n (%) 3 (60.0) 16 (69.6) Age, n (%), years <65 0 (0.0) 13 (56.5) (20.0) 6 (26.1) (80.0) 2 (8.7) >75 0 (0.0) 2 (8.7) Time intervals, n (%), days <90 1 (20.0) 2 (8.7) (0.0) 8 (34.8) (0.0) 5 (21.7) >360 4 (80.0) 8 (34.8) Cell types, n (%) AIS 2 (40.0) 21 (91.4) MIA 1 (20.0) 1 (4.3) ADC 2 (40.0) 1 (4.3) Size on CT, median, mm Size on pathology, median, mm ADC ¼ adenocarcinoma; AIS ¼ adenocarcinoma in situ; CT ¼ computed tomography; MIA ¼ minimally invasive adenocarcinoma; pggos ¼ pure ground glass opacities.
5 GENERAL THORACIC 1194 CHO ET AL Ann Thorac Surg GROUND-GLASS OPACITY NODULES AFTER SURGICAL RESECTION 2013;96: pggos, upon a surgeons preference, surgical resection was performed for lesions larger than 5 mm in some cases, or lesions larger than 1 cm were sometimes put under close observation for a certain period of time [10].If no size change was observed after a certain period of time, especially in case of peripheral lesions, the operation was performed by VATS, which enables a simple, less invasive procedure. In the study by Ohta and colleagues [1], pggos underwent VATS wedge resection after CT-guided marking if the tumors had not diminished after several months of follow-up. They suggested that although an increase in size or density absolutely required surgical removal, a decrease in size did not exclude such a requirement. However, no existing evidence shows that operation is not required for pggos that show no change. Hence, studying the outcomes in patients who have undergone surgical resection for pggos without change in size or density during follow-up could generate a guideline on whether or not this group of patients needs surgical treatment. In our study, 59% of the patients without any change were diagnosed with cancer, and 41% were diagnosed with benign tumors. It is noteworthy that among 16 patients with benign tumors, 13 patients were diagnosed with AAH. Given that AAH is thought to be a precursor or even an early-stage lesion of bronchioloalveolar carcinoma or adenocarcinoma [11, 12], more than 90% of patients could have been associated with lung cancer. Among the 23 patients diagnosed with lung cancer, 21 patients (91.4%) had either very-early-stage lung cancer or indolent AIS, which was previously defined as bronchioloalveolar carcinoma of Noguchi type A or B [13]. Therefore, it may be fair to diagnose patients in the no-change group with cancer and to perform surgical resection in those patients. However, to provide firm evidence to support the idea that surgical resection should be performed in patients in a no-change group, the prognosis of the no-change group after the procedure, such as lymph node metastasis or the recurrence rate, should first be determined. Not solely because they are diagnosed with cancer, but also because recurrence rates and lymph node metastasis are different between the two groups, surgical resection could be an acceptable approach to detection and treatment in the early stage. However, this study did not show any differences in lymph node metastasis or recurrence rate between the two groups, although a longer follow-up period should be required because a 5-year period is not a sufficient follow-up time for lung cancer featuring GGO [14]. Among the 5 patients who experienced a change in size or density, the rate of invasive adenocarcinoma was as high as 40% (2/5), but the sizes of the total lesion and invasive component were 20 and 12 mm, and 11 mm and 7 mm in each patient, respectively. This means that even though the lesions were invasive adenocarcinoma, because they were very small early-stage cancer, it cannot be said that the operations were performed late. Whether or not this slight growth can change the patients prognosis is unknown; however, this type of disadvantage is much smaller for subsolid than for solid nodules [15]. Therefore, the operation can be performed when nodules grow in size or solid components are newly formed, which supports current surgical indications for pggos. One issue this study further explored was whether or not older patients with pggos should undergo operation. With longer life expectancy and increasing interest in health, more regular health checkups have been implemented in elderly people. In this study as well, 5 of 10 patients who were older than 70, had pggos detected on the low-dose CT scan from a regular health checkup, and 4 of those patients were diagnosed with cancer. Accurate evaluation of recurrence and survival in those 4 patients should be obtained from additional follow-up. However, the authors personally suggest that surgical indication could be limited to the change group in elderly patients and also suggest that the operation be performed when the solid component has newly formed rather than when the size has increased. Evidence for this was reported in some studies in which the maximum dimension of only the solid component was found to be a more suitable prognostic factor than the maximum tumor dimension [16]. In other words, simple growth on images proving pathologic growth of the GGO portion will not have an influence on prognosis, but CT images showing a newly formed solid component, which is pathologically invasive, will have a great influence on prognosis. There were some limitations of this study. Because the study was retrospective, the surgeons preference may have been affected too much by the surgical indications, and owing to the relatively short follow-up, differences in recurrence or cancer-related death could not be identified. In conclusion, this study showed the pathology of persistent stable pggo postoperatively, which confirmed the 59% chance of the cancer diagnosis including AIS, MIA, or invasive adenocarcinoma. References 1. Ohta Y, Shimizu Y, Kobayashi T, et al. Pathologic and biological assessment of lung tumors showing ground-glass opacity. Ann Thorac Surg 2006;81: Godoy MCB, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009;253: Lee HY, Lee KS. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging 2011;26: Yoshida J, Nagai K, Yokose T, et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg 2005;129: Chang B, Hwang JH, Choi YH, et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose computed tomography. Chest 2013;143: Suzuki K, Asamura H, Kusumoto M, Kondo H, Tsuchiya R. Early peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002;74: Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996;200: Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:
6 Ann Thorac Surg CHO ET AL 2013;96: GROUND-GLASS OPACITY NODULES AFTER SURGICAL RESECTION 9. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002;73: Oh JY, Kwon SY, Yoon HI, et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer 2007;55: Kitamura H, Kameda Y, Ito T, Hayashi H. Atypical adenomatous hyperplasia of the lung: implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol 1999;111: Pueblitz S, Hieger LR. Expression of p53 and CEA in atypical adenomatous hyperplasia of the lung. Am J Surg Pathol 1997;21: Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995;75: Nakao M, Yoshida J, Goto K, et al. Long-term outcomes of 50 cases of limited-resection trial for pulmonary groundglass opacity nodules. J Thorac Oncol 2012;7: Matsuguma H, Mori K, Nakahara R, et al. Characteristics of subsolid pulmonary nodules which show growth during follow-up with computed tomography. Chest 2013;143: Maeyashiki T, Suzuki K, Hattori A, Matsunaga T, Takamochi K, Oh S. The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer. Eur J Cardiothorac Surg 2013;43: GENERAL THORACIC INVITED COMMENTARY The introduction of multidetector computed tomography (CT) scanners that acquire high-resolution, thin-section images has vastly advanced our ability to detect lung nodules. This new technology has unveiled for us a world of pulmonary nodules not previously appreciated. These include nodules that either are familiarly solid but increasingly smaller or others that are so subtle in texture that they escaped detection by prior generations of CT scanners. These latter nodules, commonly referred to as pure ground glass nodules (pggns), are hazy attenuations of the lung parenchyma that do not obscure the underlying lung architecture. Although these nodules are frequently (but not always) associated with lung cancer, they present the clinician and radiologist with a difficult dilemma because their precise natural history and pathologic characteristics are not well defined. In this issue of The Annals, Cho and colleagues [1] confront this challenge head on and report the pathologic findings in 53 patients with pggns who underwent surgical resection. The core of their message lies in the 39 patients whose pggns remained stable after 1 month of followup. In this group, lung cancer was found in 23 patients (91% adenocarcinoma in situ). The authors conclude that It could be rational to perform surgery on the no change group since 92.3% of those patients who underwent surgery were diagnosed with lesions related to cancer. For the sake of scientific discourse, this commentary will take the position that the truth about managing pggns is yet to be revealed. For starters, the study is limited by the absence of that commonly overlooked variable: the missing denominator. A recent study from the author s institution reported on 143 pggns, of which more than 80% remained stable in size and texture after a follow-up period of 4 years [2]. Therefore, it seems likely that the current study may reflect the results in a highly selected group of patients referred for surgical consideration. Interestingly, investigators of the prospective randomized Multicenteric Italian Lung Detection trial (MILD) recently reported on 48 pggns detected in the low-dose CT arms of the trial [3]. Of those lesions, 39% either resolved or decreased in size after a mean follow-up time of 50 months. These results from a prospective controlled trial clearly show that the malignant propensity of these unique abnormalities is not preordained. Assuming that some of the remaining nonresolving pggns are in fact adenocarcinoma in situ, one must wonder about the biologic behavior of these tumors and whether they should be considered within the scope of overdiagnosed cancers. If these are truly indolent lesions, then surgical resection would be considered as overtreatment for a pseudodisease. This is a seminal issue as we consider the wider implementation of CT screening for lung cancer, wherein the potential for harm and unnecessary treatment are not trivial. This is especially pertinent because the intraoperative localization of these lesions is problematic and might lead to lobar resection for what eventually proves to be benign disease. Finally, and as is often said, context is everything. The detection of pggns in otherwise healthy individuals in a screening program may have different implications than the detection of pggns by surveillance of patients with a history of lung cancer, in whom the probability of a second primary lung cancer seems higher. Until the results of prospective controlled trials are available for guidance, surgical intervention for pggns should be carefully considered and applied only if the nodule shows evidence of growth or the emergence of a solid component. Therefore, this commentary counsels: primum non nocere. Nasser K. Altorki, MD Division of Thoracic Surgery Department of Cardiothoracic Surgery Suite M-404 Weill Cornell Medical College 525 E 68th St New York, NY nkaltork@med.cornell.edu References 1. Cho S, Yang HC, Kim K, Jheon S. Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection. Ann Thorac Surg 2013;96: Lee SW, Leem CS, Kim TJ, et al. The long-term course of ground-glass opacities detected on thin-section computed tomography. Respir Med 2013;107: Silva M, Sverzellati N, Manna C, et al. Long-term surveillance of ground-glass nodules: evidence from the MILD trial. J Thorac Oncol 2012;7: Ó 2013 by The Society of Thoracic Surgeons /$36.00 Published by Elsevier Inc
Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma
ORIGINAL ARTICLE Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Jhingook Kim, MD, PhD,* Young Mog Shim, MD,
More informationWith recent advances in diagnostic imaging technologies,
ORIGINAL ARTICLE Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Kwhanmien Kim, MD,* Young Mog
More informationOBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.
Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management
More informationWhack-a-mole strategy for multifocal ground glass opacities of the lung
Review Article Whack-a-mole strategy for multifocal ground glass opacities of the lung Kenji Suzuki General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan Correspondence to: Kenji
More informationThe Spectrum of Management of Pulmonary Ground Glass Nodules
The Spectrum of Management of Pulmonary Ground Glass Nodules Stanley S Siegelman CT Society 10/26/2011 No financial disclosures. Noguchi M et al. Cancer 75: 2844-2852, 1995. 236 surgically resected peripheral
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationThe long-term course of ground-glass opacities detected on thin-section computed tomography
Respiratory Medicine (2013) 107, 904e910 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed The long-term course of ground-glass opacities detected on thin-section
More informationLUNG NODULES: MODERN MANAGEMENT STRATEGIES
Department of Radiology LUNG NODULES: MODERN MANAGEMENT STRATEGIES Christian J. Herold M.D. Department of Biomedical Imaging and Image-guided Therapy Medical University of Vienna Vienna, Austria Pulmonary
More informationCorrelation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma
Original Article Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma Yingying Miao 1,2 *, Jianya Zhang 1,2 *, Jiawei Zou 1,2, Qingqing
More informationThe small subsolid pulmonary nodules. What radiologists need to know.
The small subsolid pulmonary nodules. What radiologists need to know. Poster No.: C-1250 Congress: ECR 2016 Type: Educational Exhibit Authors: L. Fernandez Rodriguez, A. Martín Díaz, A. Linares Beltrán,
More informationThoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis
19 th Congress of APSR PG of Lung Cancer (ESAP): Update of Lung Cancer Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis Kazuma Kishi, M.D. Department of Respiratory Medicine,
More informationSolid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor
Cho et al. BMC Pulmonary Medicine (2018) 18:151 https://doi.org/10.1186/s12890-018-0709-2 RESEARCH ARTICLE Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor
More informationResults of Wedge Resection for Focal Bronchioloalveolar Carcinoma Showing Pure Ground-Glass Attenuation on Computed Tomography
Results of Wedge Resection for Focal Bronchioloalveolar Carcinoma Showing Pure Ground-Glass Attenuation on Computed Tomography Shun-ichi Watanabe, MD, Toshio Watanabe, MD, Kazunori Arai, MD, Takahiko Kasai,
More informationXiaohuan Pan 1,2 *, Xinguan Yang 1,2 *, Jingxu Li 1,2, Xiao Dong 1,2, Jianxing He 2,3, Yubao Guan 1,2. Original Article
Original Article Is a 5-mm diameter an appropriate cut-off value for the diagnosis of atypical adenomatous hyperplasia and adenocarcinoma in situ on chest computed tomography and pathological examination?
More informationCharacteristics of Subsolid Pulmonary Nodules Showing Growth During Follow-up With CT Scanning
CHEST Original Research Characteristics of Subsolid Pulmonary Nodules Showing Growth During Follow-up With CT Scanning Haruhisa Matsuguma, MD ; Kiyoshi Mori, MD ; Rie Nakahara, MD ; Haruko Suzuki, MD ;
More informationI appreciate the courtesy of Kusumoto at NCC for this presentation. What is Early Lung Cancers. Early Lung Cancers. Early Lung Cancers 18/10/55
I appreciate the courtesy of Kusumoto at NCC for this presentation. Dr. What is Early Lung Cancers DEATH Early period in its lifetime Curative period in its lifetime Early Lung Cancers Early Lung Cancers
More informationPrognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule
Original Article Prognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule Jong Hui Suh 1, Jae Kil Park 2, Youngkyu Moon 2 1 Department of Thoracic & Cardiovascular Surgery,
More informationOriginal Article Clinical predictors of lymph node metastasis in lung adenocarcinoma: an exploratory study
Int J Clin Exp Med 2016;9(5):8765-8769 www.ijcem.com /ISSN:1940-5901/IJCEM0017315 Original Article Clinical predictors of lymph node metastasis in lung adenocarcinoma: an exploratory study Zhijun Zhu,
More informationSince the introduction of low-dose helical computed tomography
Original Article Prognostic Impact of Tumor Size Eliminating the Ground Glass Opacity Component Modified Clinical T Descriptors of the Tumor, Node, Metastasis Classification of Lung Cancer Shota Nakamura,
More informationThe prognostic significance of central fibrosis of adenocarcinoma
Prognostic Significance of the Size of Central Fibrosis in Peripheral Adenocarcinoma of the Lung Kenji Suzuki, MD, Tomoyuki Yokose, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, Kenro Takahashi, MD, Kanji
More informationUniportal video-assisted thoracoscopic surgery segmentectomy
Case Report on Thoracic Surgery Page 1 of 5 Uniportal video-assisted thoracoscopic surgery segmentectomy John K. C. Tam 1,2 1 Division of Thoracic Surgery, National University Heart Centre, Singapore;
More informationPulmonary Nodules & Masses
Pulmonary Nodules & Masses A Diagnostic Approach Heber MacMahon The University of Chicago Department of Radiology Disclosure Information Consultant for Riverain Technology Minor equity in Hologic Royalties
More informationThe IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view
Review Article The IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view Wentao Fang 1, Yangwei Xiang 1, Chenxi Zhong 1, Qunhui Chen 2 1 Department of Thoracic Surgery, 2 Department
More informationHow Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?
Original Article How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed? Yoshihisa Kobayashi, MD,* Takayuki Fukui, MD,* Simon Ito, MD,* Noriyasu Usami, MD,* Shunzo Hatooka, MD,* Yasushi
More informationNatural History of Pure Ground-Glass Opacity After Long-Term Follow-up of More Than 2 Years
Natural History of Pure Ground-Glass Opacity After Long-Term Follow-up of More Than 2 Years Ken Kodama, MD, Masahiko Higashiyama, MD, Hideoki Yokouchi, MD, Koji Takami, MD, Keiko Kuriyama, MD, Yoko Kusunoki,
More informationFactors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas
Ye et al. World Journal of Surgical Oncology 2014, 12:42 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas Bo
More informationPredictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer
Original Article Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer Feichao Bao, Ping Yuan, Xiaoshuai Yuan, Xiayi Lv, Zhitian Wang, Jian Hu Department
More informationCT Screening for Lung Cancer: Frequency and Significance of Part-Solid and Nonsolid Nodules
Claudia I. Henschke 1 David F. Yankelevitz 1 Rosna Mirtcheva 1 Georgeann McGuinness 2 Dorothy McCauley 1 0lli S. Miettinen 3 for the ELCAP Group Received June 19, 2001; accepted after revision November
More informationHRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules
Original Article HRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules Wei Yu 1, Zhaoyu Wang 2, Liyong Qian 2, Shanjun Wang
More informationAlthough ipsilateral intrapulmonary metastasis (PM), Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis
Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis Morihito Okada, MD, Noriaki Tsubota, MD, Masahiro Yoshimura, MD, Yoshifumi Miyamoto, MD, and Reiko Nakai,
More informationLYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG
LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Takehiro Watanabe, MD a Yuzo Kurita, MD b Akira Yokoyama, MD b Keiichi
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationIncremental value of contrast enhanced computed tomography on diagnostic accuracy in evaluation of small pulmonary ground glass nodules
Original Article Incremental value of contrast enhanced computed tomography on diagnostic accuracy in evaluation of small pulmonary ground glass nodules Ming Li 1 *, Feng Gao 1 *, Jayender Jagadeesan 2,
More informationStage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis
Original Article Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis Jingxu Li, Xinguan Yang, Tingting
More informationSublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer
Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko Higashiyama, MD, PhD, Tomio Nakayama, MD, PhD,
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationGuidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening
Guidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening 1. Introduction In January 2005, the Committee for Preparation of Clinical Practice Guidelines for the Management
More informationInvasive Pulmonary Adenocarcinomas versus Preinvasive Lesions Appearing as Ground-Glass Nodules: Differentiation by Using CT Features 1
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Sang Min Lee, MD
More informationThe revised lung adenocarcinoma classification an imaging guide
Review Article The revised lung adenocarcinoma classification an imaging guide Natasha Gardiner 1, Sanjay Jogai 2, Adam Wallis 3 1 Specialty Registrar in Clinical Radiology, Wessex Deanery, UK; 2 Consultant
More informationSurgical resection is the first treatment of choice for
Predictors of Lymph Node and Intrapulmonary Metastasis in Clinical Stage IA Non Small Cell Lung Carcinoma Kenji Suzuki, MD, Kanji Nagai, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, and Yutaka Nishiwaki,
More informationMultifocal Lung Cancer
Multifocal Lung Cancer P. De Leyn, MD, PhD Department of Thoracic Surgery University Hospitals Leuven Belgium LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery Department of Pneumology Department
More informationAdenocarcinoma in pure ground glass nodules: histological evidence of invasion and open debate on optimal management
Editorial Adenocarcinoma in pure ground glass nodules: histological evidence of invasion and open debate on optimal management Gianluca Milanese 1, Nicola Sverzellati 1, Ugo Pastorino 2, Mario Silva 1
More informationImpalpable Pulmonary Nodules With Ground-Glass Opacity* Success for Making Pathologic Sections With Preoperative Marking by Lipiodol
CHEST Impalpable Pulmonary Nodules With Ground-Glass Opacity* Success for Making Pathologic Sections With Preoperative Marking by Lipiodol Original Research Koei Ikeda, MD, PhD; Hiroaki Nomori, MD, PhD;
More informationBronchioloalveolar carcinoma (BAC) is an imprecise term
Original Article Outcomes of Unresected Ground-Glass Nodules with Cytology Suspicious for Adenocarcinoma Caroline M. Gulati, MD,* Andrew M. Schreiner, MD, Daniel M. Libby, MD,* Jeffrey L. Port, MD, Nasser
More informationComparison of three mathematical prediction models in patients with a solitary pulmonary nodule
Original Article Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule Xuan Zhang*, Hong-Hong Yan, Jun-Tao Lin, Ze-Hua Wu, Jia Liu, Xu-Wei Cao, Xue-Ning Yang From
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationGround Glass Opacities
Ground Glass Opacities A pathologist s perspective Marie-Christine Aubry, M.D. Professor of Pathology Mayo Clinic Objectives Discuss the proposed new pathologic classification of adenocarcinoma with historical
More informationRadiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201
Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201 Hisao Asamura, MD, a Tomoyuki Hishida, MD, b Kenji Suzuki, MD, c Teruaki Koike,
More informationIn 1989, Deslauriers et al. 1 described intrapulmonary metastasis
ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,
More informationThoracoscopic wedge resection and segmentectomy for smallsized pulmonary nodules
Perspective on Thoracic Surgery Thoracoscopic wedge resection and segmentectomy for smallsized pulmonary nodules Hirohisa Kato, Hiroyuki Oizumi, Jun Suzuki, Akira Hamada, Hikaru Watarai, Kenta Nakahashi,
More informationOmission of Mediastinal Lymph Node Dissection in Lung Cancer: Its Techniques and Diagnostic Procedures
Review Omission of Mediastinal Lymph Node Dissection in Lung Cancer: Its Techniques and Diagnostic Procedures Hiroaki Nomori, MD, PhD, Kazunori Iwatani, MD, Hironori Kobayashi, MD, Atsushi Mori, MD, and
More informationNodular Ground-Glass Opacities on Thin-section CT: Size Change during Follow-up and Pathological Results
Nodular Ground-Glass Opacities on Thin-section CT: Size Change during Follow-up and Pathological Results Hyun Ju Lee, MD 1 Jin Mo Goo, MD 1 Chang Hyun Lee, MD 1 Chul-Gyu Yoo, MD 2 Young Tae Kim, MD 3 Jung-Gi
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationDoes the lung nodule look aggressive enough to warrant a more extensive operation?
Accepted Manuscript Does the lung nodule look aggressive enough to warrant a more extensive operation? Michael Kuan-Yew Hsin, MBChB, MA, FRCS(CTh), David Chi-Leung Lam, MD, PhD, FRCP (Edin, Glasg & Lond)
More informationLimited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience
Yoshida et al General Thoracic Surgery Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience Junji Yoshida, MD, a Kanji Nagai, MD, a Tomoyuki Yokose, MD, b Mitsuyo Nishimura,
More informationDIAGNÓSTICO Y TERAPIAS LOCALES. Rosario García Campelo Servicio de Oncología Médica Complejo Hospitalario Universitario A Coruña
DIAGNÓSTICO Y TERAPIAS LOCALES Rosario García Campelo Servicio de Oncología Médica Complejo Hospitalario Universitario A Coruña SIDNEY 2013 THE CHALLENGE THE THREE SISTERS: IMAGING, PATHOLOGY AND LOCAL
More informationGround-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights
Review Article Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights Yoshihisa Kobayashi 1,2, Chiara Ambrogio 2, Tetsuya Mitsudomi 1 1 Department of Thoracic Surgery,
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationLung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial
Cardiopulmonary Imaging Original Research Yip et al. Lung Cancers Manifesting as Part-Solid Nodules Cardiopulmonary Imaging Original Research Rowena Yip 1 Claudia I. Henschke 1 Dong Ming Xu 1 Kunwei Li
More informationA variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study
ORIGINAL ARTICLE A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study Joon-Hyop Lee, MD, Yoo Seung Chung, MD, PhD,* Young Don Lee, MD, PhD
More informationPULMONARY NODULES AND MASSES : DIAGNOSTIC APPROACH AND NEW MANAGEMENT GUIDELINES. https://tinyurl.com/hmpn2018
PULMONARY NODULES AND MASSES : DIAGNOSTIC APPROACH AND NEW MANAGEMENT GUIDELINES Heber MacMahon MB, BCh Department of Radiology The University of Chicago https://tinyurl.com/hmpn2018 Disclosures Consultant
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationLymph node dissection for lung cancer is both an old
LOBE-SPECIFIC EXTENT OF SYSTEMATIC LYMPH NODE DISSECTION FOR NON SMALL CELL LUNG CARCINOMAS ACCORDING TO A RETROSPECTIVE STUDY OF METASTASIS AND PROGNOSIS Hisao Asamura, MD Haruhiko Nakayama, MD Haruhiko
More informationGUIDELINES FOR PULMONARY NODULE MANAGEMENT : RECENT CHANGES AND UPDATES
Venice 2017 GUIDELINES FOR PULMONARY NODULE MANAGEMENT : RECENT CHANGES AND UPDATES Heber MacMahon MB, BCh Department of Radiology The University of Chicago Disclosures Consultant for Riverain Medical
More informationNavigational bronchoscopy-guided dye marking to assist resection of a small lung nodule
Case Report on Aerodigestive Endoscopy Navigational bronchoscopy-guided dye marking to assist resection of a small lung nodule Jennifer L. Sullivan 1, Michael G. Martin 2, Benny Weksler 1 1 Division of
More informationEvidence based approach to incidentally detected subsolid pulmonary nodule. DM SEMINAR July 27, 2018 Harshith Rao
Evidence based approach to incidentally detected subsolid pulmonary nodule DM SEMINAR July 27, 2018 Harshith Rao Outline Definitions Etiologies Risk evaluation Clinical features Radiology Approach Modifications:
More informationNovel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue
Original Article Novel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue Shin-Kwang Kang #, Jin San Bok #, Hyun Jin Cho, Min-Woong Kang Department of Thoracic
More informationApproach to Pulmonary Nodules
Approach to Pulmonary Nodules Edwin Jackson, Jr., DO Assistant Professor-Clinical Director, James Early Detection Clinic Department of Internal Medicine Division of Pulmonary, Allergy, Critical Care and
More informationUpdate on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationLow-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2
Low-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2 The Committee for Management of CT-screening-detected Pulmonary Nodules 2009-2011 The Japanese Society of CT Screening
More informationLung cancer is now a major cause of death in developed
Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,
More informationVATS Metastasectomy. Inderpal (Netu) S. Sarkaria, MD, FACS
VATS Metastasectomy Inderpal (Netu) S. Sarkaria, MD, FACS Vice Chairman, Clinical Affairs Director, Robotic Thoracic Surgery Co-Director, Esophageal and Lung Surgery Institute Disclosures Speaking & Education:
More informationGTS. The Journal of Thoracic and Cardiovascular Surgery c Volume 143, Number 3 607
Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter
More informationAccomplishes fundamental surgical tenets of R0 resection with systematic nodal staging for NSCLC Equivalent survival for Stage 1A disease
Segmentectomy Made Simple Matthew J. Schuchert and Rodney J. Landreneau Department of Cardiothoracic Surgery University of Pittsburgh Medical Center Financial Disclosures none Why Consider Anatomic Segmentectomy?
More informationClinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis
Original Article Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis Seok Joo 1, Dong Kwan Kim 2, Hee Je Sim
More informationA Clinicopathological Study of Resected Subcentimeter Lung Cancers: A Favorable Prognosis for Ground Glass Opacity Lesions
A Clinicopathological Study of Resected Subcentimeter Lung Cancers: A Favorable Prognosis for Ground Glass Opacity Lesions Hisao Asamura, MD, Kenji Suzuki, MD, Shun-ichi Watanabe, MD, Yoshihiro Matsuno,
More informationVolume and Mass Doubling Times of Persistent Pulmonary Subsolid Nodules Detected in Patients without Known Malignancy 1
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Original Research
More informationThe lung adenocarcinoma guidelines: what to be considered by surgeons
Review Article The lung adenocarcinoma guidelines: what to be considered by surgeons Rodrigo A. S. Sardenberg 1, Evandro Sobroza Mello 1, Riad N. Younes 2 1 Hospital Alemão Oswaldo Cruz, São Paulo, Brazil;
More informationExtent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationExpert Round Table with Drs. Anne Tsao and Alex Farivar Part 1: Elderly Man with Indolent Bronchioloalveolar Carcinoma
Expert Round Table with Drs. Anne Tsao and Alex Farivar Part 1: Elderly Man with Indolent Bronchioloalveolar Carcinoma February 2010 I d like to welcome everyone, thanks for coming out to our lunch with
More informationCT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationObjectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival
Objectives Appraise lung cancer screening trials results Review screening guidelines Lung Cancer Screening: Past, Present and Future Chi Wan Koo, MD Koo.chiwan@mayo.edu Discuss recommendations essential
More informationRecommendations for the Management of Subsolid Pulmonary Nodules Detected at CT: A Statement from the Fleischner Society 1
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Original Research
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationIs There a Role for FDG PET in the Management of Lung Cancer Manifesting Predominantly as Ground-Glass Opacity?
Cardiopulmonary Imaging Original Research Kim et al. Role of FDG PET in Ground-Glass Opacity Lung Cancer Cardiopulmonary Imaging Original Research Tae Jung Kim 1 Chang Min Park 2 Jin Mo Goo 2 Kyung Won
More informationShould minimally invasive lung adenocarcinoma be transferred from stage IA1 to stage 0 in future updates of the TNM staging system?
Original Article Should minimally invasive lung adenocarcinoma be transferred from stage to stage 0 in future updates of the TNM staging system? Tianxiang Chen 1,2#, Jizhuang Luo 3#, Haiyong Gu 3, Yu Gu
More informationHistory of Limited Resection for Non-small Cell Lung Cancer
Review History of Limited Resection for n-small Cell Lung Cancer Haruhiko Nakamura, MD, PhD, 1 Sugishita Kazuyuki, MD, 1 rihito Kawasaki, MD, 1 Masahiko Taguchi, MD, PhD, 1 and Harubumi Kato, MD, PhD 2
More informationVisceral pleural involvement (VPI) of lung cancer has
Visceral Pleural Involvement in Nonsmall Cell Lung Cancer: Prognostic Significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu, MD, PhD, Sosuke Yamada, MD, and Kosei Yasumoto,
More informationLung cancer is the most common cause of cancer death in
ORIGINAL ARTICLE Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and Mutations in Patients with Adenocarcinoma of the Lung with Bronchioloalveolar Features? Catherine
More informationSmall solid noncalcified pulmonary nodules detected by screening chest computed tomography
Respiratory Medicine (2007) 101, 1880 1884 Small solid noncalcified pulmonary nodules detected by screening chest computed tomography Sang-Man Jin a,b, Seung-Ho Choi c, Chul-Gyu Yoo a,b, Young-Whan Kim
More informationCT Findings of Atypical Adenomatous Hyperplasia in the Lung
CT Findings of typical denomatous Hyperplasia in the Lung Chang Min Park, MD 1 Jin Mo Goo, MD 1 Hyun Ju Lee, MD 1 Chang Hyun Lee, MD 1 Hyo-Cheol Kim, MD 1 Doo Hyun Chung, MD 2 Jung-Gi Im, MD 1 Index terms:
More informationVisceral pleura invasion (VPI) was adopted as a specific
ORIGINAL ARTICLE Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database Junji Yoshida,
More informationPleomorphic carcinoma of the lung: which CT findings predict poor prognosis?
Pleomorphic carcinoma of the lung: which CT findings predict poor prognosis? Poster No.: C-1887 Congress: ECR 2015 Type: Scientific Exhibit Authors: A. Fujisaki, T. Aoki, S. Kinoshita, Y. Hayashida, Y.
More informationStandard treatment for pulmonary metastasis of non-small
ORIGINAL ARTICLE Resection of Pulmonary Metastasis of Non-small Cell Lung Cancer Kenichi Okubo, MD,* Toru Bando, MD,* Ryo Miyahara, MD,* Hiroaki Sakai, MD,* Tsuyoshi Shoji, MD,* Makoto Sonobe, MD,* Takuji
More informationCarcinoma of the Lung
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and
More informationThe detection rate of small nodules with ground-glass
ORIGINAL ARTICLE Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation Between Multiple Lung Nodules with Ground-Glass Opacity Differentiates Multicentric Origin from Intrapulmonary
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More information